Association of Performance Status and Pain in Metastatic Bone Pain Management in the Spanish Clinical Setting

Introduction Bone metastasis is the most common cause of cancer-related pain, and metastatic bone pain (MBP) is not only severe but also progressive in many patients. The aim of this study was to investigate the association between pain management and performance status in patients with metastatic b...

Full description

Saved in:
Bibliographic Details
Published in:Advances in therapy 2017, Vol.34 (1), p.136-147
Main Authors: Dómine Gómez, Manuel, Díaz Fernández, Nieves, Cantos Sánchez de Ibargüen, Blanca, Zugazabeitia Olabarría, Luis, Martínez Lozano, Joaquina, Poza de Celis, Raúl, Trujillo Vílchez, Rafael, Peláez Fernández, Ignacio, Capdevila Castillón, Jaume, Traseira Lugilde, Susana, Esteban González, Emilio
Format: Article
Language:English
Subjects:
Aged
Analgesics - therapeutic use
Analgesics, Opioid - therapeutic use
Bone Neoplasms - secondary
Cancer Pain - drug therapy
Cancer Pain - therapy
Cardiology
Endocrinology
Female
Health Status
Health technology assessment
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Oncology
Original Research
Pain Management - methods
Pharmacology/Toxicology
Prospective Studies
Rheumatology
Spain
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Bone metastasis is the most common cause of cancer-related pain, and metastatic bone pain (MBP) is not only severe but also progressive in many patients. The aim of this study was to investigate the association between pain management and performance status in patients with metastatic bone cancer in the Spanish clinical setting. Methods A 3-month follow-up prospective, epidemiologic, multicenter study was conducted in 579 patients to assess the evolution of their performance, the impact of pain control on sleep and functionality, and the degree of pain control according to analgesic treatment. Results In patients with MBP, Eastern Cooperative Oncology Group (ECOG) status (1.5 ± 0.7–1.3 ± 0.7 and 1.3 ± 0.8; p  
ISSN:0741-238X
1865-8652
DOI:10.1007/s12325-016-0435-1